A

Apellis Pharmaceuticals

D
APLS
USD
-0.21
(-0.7436%)
Market Closed
147,406.00
حجم التداول
-1.29
الربح لكل سهم
-
العائد الربحي
-10.305147
P/E
3,413,110,173.84
حجم السوق
اليوم
-0.7436%
1 اسبوع
-2.572%
1 شهر
2.374%
6 اشهر
-31.983%
12 اشهر
-41.822%
بداية السنة
-53.166%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Apellis Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
هل تحتاج مساعدة او لديك استفسار؟